This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
An in silico investigation of the phytomolecules present in Piper longum roots as a potential treatment for SARS-CoV-2 (preprint)
researchsquare; 2023.
Preprint
in English
| PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-3100291.v1
ABSTRACT
The epidemic of COVID-19 brought on by SARS-CoV-2 (coronavirus related to SARS) as well as its variants is still a life-threatening and critical risk to public health around the world. Due to the COVID-19 virus's propensity for mutation, the pandemic is still spreading havoc compared to SARS-CoV-2. Several phytochemicals are now undergoing in silico analysis for their anti-SARS-CoV-2 efficacy. Scientists all over the world are on the lookout for novel lead phytochemicals that can effectively block SARS-CoV-2 entrance and infection in host cells. Piper longum phytomolecules suggest that it may be more effective to use natural remedies and herbal extracts to improve immunity and fight the infection. In this current in silico study of different Piper longum phytochemicals like sesamin, piperine, gamma-sitosterol, and epizonarene, Utilizing Lipinski's rule, study the drugability guidelines and oral bioavailability of these compounds. Four putative SARS-CoV-2 therapeutic targets were explored using the top four ligands in a comparative study. Our finding shows that sesamin, piperine, gamma-sitostenone, and epizonarene all displayed binding affinity values of -8.9, -7.8, -7.4, and − 7.2 kcal/mol, respectively. Sesamin was found to have a greater negative binding energy toward the SARS-CoV-2 targets, which is a significant finding. We concluded that sesamin may be effective as a treatment for SARS-CoV-2.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-RESEARCHSQUARE
Main subject:
Parkinson Disease
/
COVID-19
Language:
English
Year:
2023
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS